Leadership & Pay ·
Nasdaq grants cure period for SKYX after board member death causes compliance lapse
SKYXSKYX Platforms Corp.
SKYX Platforms Corp. reported the death of independent board member Efrat L. Greenstein Brayer on September 26, 2026. Her passing caused the company to fall out of compliance with Nasdaq Listing Rules requiring a majority of independent directors and an audit committee of at least three members. Nasdaq granted a cure period expiring upon the next annual meeting or September 26, 2027, contingent on holding that meeting before March 25, 2027. The company intends to regain compliance but cannot assure success within the timeframe. This listing issue does not immediately affect its Nasdaq status. SKYX Platforms Corp. operates in the technology sector, specializing in digital marketing and advertising solutions.